Navigation Links
Millions Around the World to Have Access to Low-Cost HIV Test by 2013
Date:6/20/2012

MELBOURNE, Australia, June 20, 2012 /PRNewswire/ -- For the first time, HIV patients in developing countries will have access to an affordable diagnostic test to determine if they should start life-saving antiretroviral drugs.

The Burnet Institute in Melbourne has announced a licensing agreement with Omega Diagnostics Group PLC, a global diagnostics organisation, to commercialise the point-of-care CD4 test for use worldwide, including aid agencies delivering frontline health services.

Omega has manufactured a first small-scale batch of prototype devices but reports there is still further work to do in terms of manufacturing scale-up and field trial evaluations before the first commercial sale of product. The company will host the commercial launch of the POC CD4 test at the 19th International AIDS Conference, AIDS 2012, to be held in Washington DC from 22-27 July.

Burnet Institute Deputy Director, Associate Professor David Anderson developed the low-cost test along with Co-head of Burnet's Centre for Virology Professor Suzanne Crowe AM.

"According to UNAIDS, there are 15 million people who should be getting access to antiretroviral therapy but aren't, just because they can't get access to an affordable CD4 test in their communities," Associate Professor Anderson said.

The CD4 test uses a small amount of blood from a finger-prick with results available after 40 minutes at a cost significantly less than the existing tests.

Current tests to determine CD4 cell count cost more than AUD $10. It requires trained health workers to collect venous blood and highly trained technicians to perform the tests on expensive equipment requiring power, clean water and regular maintenance.

"It's easy to diagnose HIV but it's hard to identify those who need therapy, this test will change that, providing cost effective testing for up to 33 million patients worldwide," Professor Anderson said.

Aid agencies in Papua New Guinea, India and South Africa are likely to be among the first to access the Burnet CD4 test.

This is the culmination of six years work by Associate Professor Anderson, Professor Crowe AM, Mary Garcia, Nadine Barnes, Simone Van de Waarsenburg, Jocelyn Diaz, Robyn Lloyd and Joy Liu at Burnet. It was also developed in collaboration with Professor Alan Landay from Rush University in Chicago and Professor Thomas Denny from Duke University in North Carolina.

To arrange an interview with Associate Professor David Anderson please contact:
Catherine Somerville
Media and Communications Officer, Burnet Institute
Ph: +61 422 043 498 or email: cathsomerville@burnet.edu.au  


'/>"/>
SOURCE Burnet Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
2. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
3. Ophthalmic Drugs: World Market Prospects 2012-2022
4. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
5. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
6. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
7. Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
8. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
9. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
10. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
11. DebMed® to Debut Benefits of Worlds First Electronic Hand Hygiene Compliance Monitoring System Using the WHO Five Moments at Annual Infection Control Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):